A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Clinical trial NCT05780034 · RECRUITING
Trial details
- NCT number
- NCT05780034
- Sponsor
- Accutar Biotechnology Inc
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-20
- Primary completion
- 2026-03-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.